CTLA4 and melanoma: Copy number deletion of the IFN  gene cluster may also leads to a worse prognosis in melanoma patients [13] and could be useful as a prognostic marker to predict resistance to immunotherapy (e.g., anti-CTLA4 treatment) [11].